2'MeO6MF  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:100mg in glass bottle
产品描述:基本信息 产品编号: M11269  产品名称: 2'MeO6MF CAS: 89112-85-6   储存条件 粉末 -20℃ 四年 分子式: C17H14O3 溶于液体 -80℃ 二年 分子量: 266.29     化学名:  4H-1-Benzopyran-4-one,2-(2-methoxyphenyl)-6-methyl- Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 一种可透过血脑屏障的α2β1γ2L和所有含α1的GABAA受体的正变构调节剂。2'MeO6MF也可以直接激活α2β2/3和α2β2/3γ2LGABAA受体。2'MeO6MF具有抗焦虑和镇静作用。2'MeO6MF可提供神经保护作用并改善功能恢复,还可抑制中风诱发的炎症反应。 靶点 GABAA receptor   体外研究 2'MeO6MF (100-300µM;60 min) weakly displaces [3H]-flunitrazepam binding to rat brain synaptosomal membranes by 5-10%.2'MeO6MF enhances [3H]-muscimol binding to rat brain synaptic membranes in a concentration-dependent manner yielding a mean Emax of 219.8% and apparent EC50=20.8nM.2'MeO6MF (1-300µM) enhances the response elicited by a low concentration of GABA in a concentration-dependent manner at recombinant α1β2γ2L GABAA receptors expressed in XenopusM oocytes.2'MeO6MF enhances the response elicited by GABA at recombinant α1β1,3γ2L and α1β2 GABAA receptors without any direct activation.2'MeO6MF (1-10µM;60 min) increases tonic inhibitory currents in a concentration-dependent manner in granule cells.2'MeO6MF (100-1000µM;6.5h) inhibits the LPS-induced increase of NFkB activity in RAWblueTM macrophage cells. 体内研究 2'MeO6MF (1-100mg/kg;i.p.) displays anxiolytic-like effects in the elevated plus maze and light/dark tests.2'MeO6MF induces sedative effects at higher doses in the holeboard,actimeter and barbiturate-induced sleep time tests.2'MeO6MF (30mg/kg;i.p.) increases tonic currents in layer 2/3 pyramidal neurons of mice after stroke.2'MeO6MF (0.1-30mg/kg;i.p.) is neuroprotective and enhances functional recovery after focal cerebral ischaemia in mice. Animal Model: Male Balb-c mice (8-10 weeks,25-35g) Dosage: 1,10,30,100mg/kg Administration: I.p. Result: No overt acute toxicity was observed.Exerted anxiolytic effects at low doses and sedative effects at high doses without myorelaxant effects.
保存条件:-20℃